Medicare Enrolled
Dr. Fahd Al-Saghir, MD
Nephrology · Pontiac, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Al-Saghir from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Al-Saghir?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Al-Saghir
Dr. Fahd Al-Saghir is a nephrology specialist in Pontiac, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Al-Saghir performed 4,916 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Al-Saghir received a total of $34,700 from 39 pharmaceutical and/or device companies across 368 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Al-Saghir is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 8% volume in MI
$34,700 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗4,916
Medicare services
Top 8% in MI for nephrology
Not available
Unique patients (not deduplicated)
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,759 | $0 | $2 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
322 | $64 | $160 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
279 | $0 | $2 |
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
245 | $285 | $950 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
188 | $62 | $210 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
175 | $38 | $159 |
| Injection, fentanyl citrate, 0.1 mg | 158 | $1 | $2 |
| Hemodialysis circuit intervention with balloon dilation A procedure to insert a needle or tube into a hemodialysis circuit and dilate the dialysis segment using a balloon, with radiological review. |
130 | $978 | $3,804 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
111 | $98 | $220 |
| Hemodialysis, single evaluation A dialysis procedure to filter waste from the blood, performed with a physician's evaluation. |
89 | $58 | $200 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
74 | $137 | $440 |
| Balloon dilation of dialysis access with radiologist review A minimally invasive procedure to widen a narrowed section of a dialysis access vessel using a balloon catheter. The procedure includes review by a radiologist to ensure proper placement and effectiveness. |
47 | $488 | $1,917 |
| Radiologist review of arm or leg artery image A radiologist reviews images of the arteries in the arm or leg. This process involves analyzing the visual data to assess the blood vessels. |
43 | $80 | $510 |
| Arterial catheter insertion, first order branch Placement of a catheter into a primary branch of an artery in the chest or arm. |
40 | $436 | $3,247 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
32 | $61 | $140 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
30 | $100 | $320 |
| Removal of tunneled central venous tube This procedure involves the removal of a catheter that has been surgically placed under the skin and threaded into a large vein. |
22 | $127 | $519 |
| Replacement of tunneled central venous tube This procedure involves replacing an existing tunneled central venous catheter with a new one. The new tube is inserted through the same tunnel under the skin to maintain vascular access. |
20 | $632 | $2,540 |
| Additional sedation, per 15 minutes Administration of a drug to deepen sedation during a procedure. This code covers each additional 15-minute increment of sedation beyond the initial period. |
18 | $9 | $30 |
| Radiologist review of arm or leg vein image A radiologist reviews an image of a vein in one arm or leg. |
17 | $63 | $338 |
| Ultrasound of arm arteries or grafts An ultrasound exam of the arteries in one arm or any arterial grafts present. This imaging test uses sound waves to visualize blood flow and vessel structure. |
17 | $67 | $380 |
| Contrast injection for X-ray imaging Administration of a contrast agent into a vein in the arm or leg to enhance visibility during an X-ray imaging procedure. |
16 | $214 | $807 |
| Fluoroscopic guidance for central vein access device Use of live X-ray imaging to guide the placement or removal of a central vein access device. |
16 | $24 | $322 |
| Needle or tube insertion into hemodialysis circuit with radiologist review A procedure involving the insertion of a needle or tube into a hemodialysis circuit, accompanied by a review of the procedure by a radiologist. |
15 | $577 | $2,220 |
| Dialysis services for adults, 2-3 visits per month This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month. |
14 | $228 | $950 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
14 | $65 | $200 |
| Radiologist review of major upper body vein image A radiologist reviews images of the major veins in the upper body to assess their structure and function. |
13 | $55 | $368 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $138 | $360 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.2% high complexity
76.7% medium
22.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$34,700
Total received (2018-2024)
Avg $4,957/year across 7 years
Top 4% in MI for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
368
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,876
2023
$969
2022
$1,793
2021
$4,311
2020
$7,798
2019
$10,376
2018
$5,576
Payments by company (2024)
CSL Behring
$2,486
Medtronic, Inc.
$333
Ardelyx, Inc.
$256
Aurinia Pharma U.S., Inc.
$166
Amgen Inc.
$153
AstraZeneca Pharmaceuticals LP
$89
CALLIDITAS THERAPEUTICS US INC.
$86
Alexion Pharmaceuticals, Inc.
$72
Travere Therapeutics, Inc.
$48
Boehringer Ingelheim Pharmaceuticals, Inc.
$40
Novartis Pharmaceuticals Corporation
$35
Novo Nordisk Inc
$33
AKEBIA THERAPEUTICS INC
$22
Fresenius USA Marketing, Inc.
$21
OPKO Pharmaceuticals, LLC
$17
Bayer Healthcare Pharmaceuticals Inc.
$17
Top 3 companies account for 79.3% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$13,060
AKEBIA THERAPEUTICS INC
$8,216
Keryx Biopharmaceuticals, Inc.
$5,064
CSL Behring
$2,486
Medtronic, Inc.
$1,536
OPKO Pharmaceuticals, LLC
$402
Vifor Pharma, Inc.
$365
Alexion Pharmaceuticals, Inc.
$328
Horizon Therapeutics plc
$317
Amgen Inc.
$315
Relypsa, Inc.
$303
Aurinia Pharma U.S., Inc.
$286
Ardelyx, Inc.
$256
GlaxoSmithKline, LLC.
$233
Mallinckrodt Hospital Products Inc.
$161
Travere Therapeutics, Inc.
$130
Fresenius USA Marketing, Inc.
$122
CALLIDITAS THERAPEUTICS US INC.
$106
Otsuka America Pharmaceutical, Inc.
$103
Bayer Healthcare Pharmaceuticals Inc.
$102
Bayer HealthCare Pharmaceuticals Inc.
$100
Boston Scientific Corporation
$84
AMAG Pharmaceuticals, Inc.
$72
Mallinckrodt LLC
$55
Novartis Pharmaceuticals Corporation
$52
Avenu Medical Inc.
$51
Mallinckrodt Enterprises LLC
$51
BARD PERIPHERAL VASCULAR, INC.
$40
Boehringer Ingelheim Pharmaceuticals, Inc.
$40
Calliditas Therapeutics US Inc.
$40
Daiichi Sankyo Inc.
$34
Novo Nordisk Inc
$33
Bard Peripheral Vascular, Inc.
$32
CORDIS US CORP.
$29
Ultragenyx Pharmaceutical Inc.
$25
Outset Medical Inc
$24
Abbott Laboratories
$19
Shire North American Group Inc
$14
Otsuka Pharmaceutical Development & Commercialization, Inc.
$13
Top 3 companies account for 75.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AURYXIA · AVANTI · Auryxia · BENLYSTA · CHAMELEON · COVERA · Critline - Monitors · Cryvista · ELLIPSYS VASCULAR ACCESS SYSTEM · Ellipsys · FARXIGA · FERAHEME · GATTEX · General - Therapies · IBSRELA · INJECTAFER · JARDIANCE · JETI · JYNARQUE · KRYSTEXXA · Kerendia · LOKELMA · LUPKYNIS · Ozempic · Parsabiv · RAYALDEE · Rayaldee · Rayaldee (old) · SAMSCA · SOLIRIS · TARPEYO · TAVNEOS · Thiola · ULTOMIRIS · Ultomiris · Velphoro · Veltassa · Venovo · Wegovy · XPHOZAH 30 MG
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Nephrologists in nearby ZIP areas
125
County median income
$95,296
Nearest hospital to ZIP centroid (approximate)
TRINITY HEALTH OAKLAND HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Al-Saghir is a mixed practice specialist, with above-average Medicare volume (top 8% in MI), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Al-Saghir experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Al-Saghir performed 2,759 contrast dye for imaging (iodine-based) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Al-Saghir receive payments from pharmaceutical companies?
Yes. Dr. Al-Saghir received a total of $34,700 from 39 companies across 368 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Al-Saghir's costs compare to other nephrologists in Pontiac?
Dr. Al-Saghir's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Al-Saghir) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in Pontiac
Browse nephrologists in Pontiac ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in MI
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in MI
Which MI nephrologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
AKEBIA THERAPEUTICS INC Payments to Doctors
See all physicians who received payments from AKEBIA THERAPEUTICS INC.
By company
Keryx Biopharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Keryx Biopharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology